Background: The aim of this study was to estimate the impact 2 and 3 years after surgery of implant-assisted latissimus dorsi (LDI) and autologous latissimus dorsi (ALD) flap breast reconstructions on patient-reported outcomes (PROs), and, secondarily, to determine whether baseline characteristics can predict PROs.
Introduction
Improvements in early detection and systemic treatments of breast cancer have resulted in 500 000 long-term survivors in the UK 1 . Currently, 53 per cent of women with (NMBR) audit 2 ; 4796 (31⋅0 per cent) of these women underwent breast reconstruction.
The loss of a breast adversely affects a range of patient-reported outcomes (PROs), which may be considered multidimensional aspects of a woman's health-related quality of life (HRQL) 3 -5 . The pedicle latissimus dorsi (LD) or 'back flap' procedure involves transferring muscle, fat and skin to the chest wall, and is commonly employed 2, 5 . The autologous tissue LD (ALD) procedure involves an extended donor/back-site dissection of tissues, potentially avoiding an implant 5 . The implant-assisted LD reconstruction (LDI) minimizes the extent of donor-site dissection, using an implant to achieve the desired volume 5 . Current evidence does not support the superiority of either type of LD procedure in terms of PROs 2,3,6 . Clinicians may favour immediate autologous procedures when postmastectomy radiotherapy (PMRT) is predicted before surgery. This is based on studies suggesting superior cosmetic outcomes, although there is poor evidence comparing this approach to delayed procedures 2,3,5 -8 .
The NMBR audit assessed PROs from 3 to 18 months using the BREAST-Q breast reconstruction questionnaire 9 . The most commonly reported adverse effects on PROs were: physical and functional difficulties with the shoulder girdle and abdomen (34 per cent reported difficulties most or all of the time); dissatisfaction with the reconstructed breast (40 per cent) and donor site (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) per cent); general pain and psychosocial difficulties per cent) 10 . In the present study, the European Organization for Research and Treatment of Cancer (EORTC) Core PRO questionnaire (QLQ-C30) 11 supplemented by the breast-specific module (QLQ-BR23) 12 and the Functional Assessment of Cancer Therapy -Breast scale (FACT-B) 13 were used. Although these questionnaires address wide-ranging issues relevant to women with breast cancer, they do not cover issues specific to breast reconstruction. Therefore, an EORTC breast reconstruction module was developed recently 14 .
A systematic review 3 of PROs after breast reconstruction showed no clinical trials and only a few prospective longitudinal cohort studies (4 of 11) that reported PROs up to 24 months after reconstruction. None of the prospective cohort studies evaluated the effects of PMRT on PROs 3 , although PMRT may confer a survival benefit when combined with systemic adjuvant therapies 15, 16 . Increasingly, there is a reliance on methodologically robust cohort studies for evidence of the comparative effectiveness of different types of reconstruction, owing to challenges in conducting randomized trials 17, 18 . There is no consensus in the literature regarding the impact and duration of breast reconstruction effects on PROs 3 . Despite the known clinical efficacy of both types of LD breast reconstruction, there is a paucity of information on the effect sizes of core PRO domains in all studies 3, 8 .
The present paper reports on an ongoing multicentre cohort study. One-year postoperative PROs have been reported previously 8 . The aim of the present study was to evaluate: effect sizes for change from baseline at 2 and 3 years after surgery on all PRO domains of two common types of breast reconstruction; which baseline factors are predictive of PRO domain scores at 2 and 3 years; which PRO domains are most sensitive to demonstrating changes over time; and what differences exist between LDI and ALD groups in PRO scores at 2 or 3 years after adjusting for clinicodemographic case mix. This will generate hypotheses and provide estimates of domain effect sizes to guide subscale selection within PROs and sample-size calculation for future studies 19 .
Methods

Study design, quality control and risk of bias
This study was developed as a protocol-driven prospective design 18 . Several clinical risk factors potentially bias the comparison of PROs in ALD versus LDI reconstructions, as higher-risk women with breast cancer are more likely to have poorer PROs at diagnosis consequent to more aggressive treatments 4, 8 . It is patients in this clinically higher-risk group who are more frequently recommended for immediate ALD rather than LDI reconstructions 8, 15 . These clinical risk factors were assessed and compared between ALD and LDI groups at baseline, and adjusted for in regression analyses of PROs.
Study sample
This was an extended follow-up (from January 2007 to May 2013) of a multicentre prospective longitudinal cohort study, ethically approved (National Research Ethics Committee Wiltshire; 05/Q2008/14) and conducted in six UK centres (Bristol, Cambridge, Glasgow, Hull, Swindon and York) 8 . Eligibility criteria have been described previously 8 ; they included women with early breast cancer (stage I-II) in one or both breasts, and excluded women with previously diagnosed breast cancer, confirmed metastatic disease, and those recommended for delayed breast reconstruction.
Detailed study processes have been described, relating to: clinical diagnosis; local multidisciplinary team decision-making regarding PMRT recommendations; dual-localization sentinel lymph node biopsy and MRI according to clinical guidelines 8, 15 . Women who consented then completed self-reported questionnaires before mastectomy and breast reconstruction (baseline) at the preoperative assessment clinic, and were subsequently posted 2-and 3-year postreconstruction questionnaires using a self-addressed envelope. Two postal reminders prompted patients to return the questionnaires. Recurrent (local or distant) disease did not exclude questionnaire administration, except in the case of cerebral metastases.
Primary endpoints
Four PRO questionnaires were used to evaluate the levels of change (expressed as the mean change from baseline at 2 and 3 years after surgery divided by the standard deviation -the effect size) in patient-reported symptoms and functioning after immediate ALD or LDI reconstructions treated with PMRT or no PMRT. The EORTC QLQ-C30 11 was used to assess core domains of quality of life (functioning and symptoms), alongside the breast cancer module, QLQ-BR23 12 , to evaluate breast and arm symptoms, sexual functioning and body image. The Hospital Anxiety and Depression Scale (HADS) 20 , distinguishing anxiety and depression, was also used. FACT-B was used to assess physical, social, emotional and functional well-being 13 . Items within each subscale of each PRO were summed and transformed to a range of 0-100 12, 13 . For body image, functioning and well-being scales, higher scores were indicative of better outcomes; positive change indicated improvement and negative change indicated worsening. In contrast, for symptom scales (breast, arms, pain and fatigue), anxiety and depression, higher scores indicated worse outcomes; positive change indicated worsening and negative change reflected improvement 12, 13 . Selection of these PROs was based on previously reported PRO studies, with no validated breast reconstruction-specific questionnaires at the time this study was designed 8, 19, 21 . In the Michigan Breast Reconstruction Outcomes Study (MBROS) 19, 21 , these PROs showed significant differences in mean scores after types of immediate and delayed breast reconstruction.
Secondary endpoints
Patients' compliance rates for completion of PROs were documented. Adverse clinical events were graded using the Dindo-Clavien classification 22 . Early surgical complications were recorded up to and including 3 months after breast reconstruction, compared with late complications occurring between 4 months and 3 years. Locoregional recurrence and distant metastatic disease were assessed using established criteria 23 .
Clinical and demographic characteristics
Clinical report forms were used to record all clinical details as described, including sociodemographic factors 8 . Additional operations (complications or cosmetic procedures) were documented over 3 years. Annual clinical follow-up was scheduled for as close as possible to the anniversary date of breast reconstruction.
Statistical analysis
As this was primarily a hypothesis-generating study, the sample size was based on obtaining sufficient numbers of women in the main treatment groups of interest to provide reasonably reliable estimates of effect size for all domains and subscales within the selected PROs. The purpose of these preliminary effect-size estimates was to guide PRO domain selection and sample-size calculation for future studies 24, 25 . At the time of analysis, the total sample was sufficiently powered to evaluate relatively small effect sizes (0⋅3) for intragroup changes from baseline to 2 years (87 per cent power) and 3 years (76 per cent) in the pooled surgical groups, and moderate effect-size changes (0⋅5) within each reconstruction group (ALD and LDI separately) (more than 95 per cent power at 2 years, more than 75 per cent at 3 years). The study was somewhat underpowered to detect moderate effect-size differences between ALD and LDI groups at 2 years (68 per cent power) and 3 years (54 per cent). Cognisant of the large number of P values generated, a cut-off of P < 0⋅010 was used to indicate statistical significance. All analyses were performed using the R program version 2.15.1 (R Foundation for Statistical Computing, Bell Laboratories, Lucent Technologies, Murray Hill, New Jersey, USA). No imputation of missing values was made, and each result was based on all patients for whom relevant data were recorded.
Baseline clinical and sociodemographic data were compared between the two surgical groups (ALD and LDI). Categorical variables, summarized as proportions, were compared using the χ 2 test or Fisher's exact test. Continuous data, summarized using mean(s.d.) or median (range) values where distributions were non-normal, were compared using Student's t test or the non-parametric rank sum test.
Mean domain score changes from baseline (preoperative) to 2 or 3 years were calculated within the whole sample and within each surgical group. Effect sizes were measured by Cohen's d 26 . The clinical significance of effect sizes for the QLQ-C30 and FACT-G data were interpreted using evidence-based guidelines 24 -27 . As similar guidance is lacking for the other PROs, general guidance was used, whereby effect sizes of less than 0⋅3 were considered small Recruited into prospective observational cohort n = 206
Baseline QLQ completed n = 104 Missing data n = 9
Baseline QLQ completed n = 78 Missing data n = 15
Total number of patients screened n = 240
Fig. 1
Progress of participants through the study in keeping with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist. Missing data signify patient non-compliance (questionnaires not returned) and administrative logistics (questionnaires not sent out and missing data entry). LDI, implant-assisted latissimus dorsi breast reconstruction; ALD, autologous latissimus dorsi breast reconstruction; QLQ, quality-of-life questionnaires; RT, postmastectomy radiotherapy; baseline, before mastectomy and immediate breast reconstruction; 24 months, 24 months after breast reconstruction; 36 months, 36 months after breast reconstruction but clinically relevant 26, 27 , effect sizes exceeding 0⋅5 were referred to as moderate and considered unequivocally clinically important, and effect sizes larger than 0⋅8 were described as large 24 -27 . Longitudinal analysis of PROs at 2 and 3 years was done by fitting a separate generalized estimating equation model for each PRO domain, including the corresponding baseline PRO value as a co-variable to improve the precision of estimates of other predictors. Each model included the following baseline variables as potential predictors: type of reconstruction, PMRT, chemotherapy (adjuvant or neoadjuvant), age at operation (50 years or more versus less than 50 years), and early (up to 3 months) and late (from 4 months to 3 years) complications for each PRO domain. The contribution of each baseline parameter to the prediction of each PRO domain was determined by the P value of the corresponding regression coefficient. As P values do not indicate the direction of an effect, each was converted to a Z score 27 (for example, a P value of 0⋅050 converts to a Z score of ±1⋅96).
A second multiple linear regression model was used to generate case-adjusted estimates of differences between LDI and ALD groups in PRO changes at 2 and 3 years. In these models, the main predictor of interest was type of surgery. Co-variables included were: baseline PRO value (to improve precision, as above), and body mass index, chemotherapy, tumour size, margin positivity, lymph node positivity, PMRT and late complications where the variable differed between surgical groups at baseline (P < 0⋅100 to be inclusive of all potential confounders); type of axillary surgery was omitted as it was considered a surrogate for lymph node positivity. Given the large number of co-variables, the Holm-Bonferroni allowance was used to adjust for multiple testing. 
Results
Two hundred and forty patients were screened prospectively at multidisciplinary meetings, with recruitment of 206 women (85⋅8 per cent) undergoing immediate LD breast reconstruction. These comprised 93 (45⋅1 per cent) LDI procedures and 113 (54⋅9 per cent) ALD reconstructions (Fig. 1) . The proportions of women undergoing ALD reconstruction were often in keeping with the clinicians' perception of the likelihood of PMRT 6 . The extent to which this decision-making materialized into administering PMRT was not recorded in this study.
Compared with women who underwent LDI procedures, those who had ALD reconstructions had a significantly higher body mass index, larger tumour, greater likelihood of lymph node positivity, and treatment with neoadjuvant or adjuvant chemotherapy as well as PMRT ( Table 1) .
A recent therapeutic wide local excision preceded a completion mastectomy owing to microscopic margin positivity in 26⋅9 per cent of women. The significantly greater margin positivity rate of 25 per cent for invasive disease in the LDI group, compared with 6⋅8 per cent in the ALD group, is largely inexplicable and would necessitate consideration of PMRT 15 . Details regarding particular contributors to margin positivity were not analysed.
There were no other significant differences in pathological characteristics between the surgical groups (data not shown) 8 . There were 16 patients with bilateral breast cancers, but only one was included owing to missing data. As reported previously 8 , women undergoing ALD reconstructions more frequently received axillary lymph node dissections, whereas those who had LDI operations had fewer axillary procedures. Previously reported clinicopathological and sociodemographic characteristics were similar between the surgical groups (data not shown) 8 . One of the 78 women who had an LDI reconstruction had a local recurrence, and five of the 104 women undergoing an ALD procedure developed distant metastases.
Patient-reported outcome questionnaire completion and missing data rates
Of the 206 recruited women, 182 (88⋅3 per cent) completed baseline questionnaires as a study prerequisite: 169 (92⋅9 per cent) at 1 year 8 , 156 (85⋅7 per cent) at 2 years and 122 (67⋅0 per cent) at 3 years ( Fig. 1) . Reasons for missing data included patient non-compliance and administrative issues. Compliance rates for questionnaire completion were consistently high: 90⋅5 per cent at baseline, 92⋅2 per cent at 2 years and 87⋅3 per cent at 3 years (data not shown). Logistical and administrative issues were: questionnaires not sent out and missing clinical data from clinical report forms.
Surgical complications
As reported previously 8 , early complications of the breast and/or donor site comprised: haematoma, infection, skin necrosis, fat necrosis and wound dehiscence. Implantrelated complications and others were also recorded. Additional donor-site complications comprised persistent seromas (arbitrarily defined as 5 or more outpatient aspirations) and back pain. There were no differences between surgical groups regarding early complications ( Table 1) . Long-term complications included: capsular contracture and implant complications, breast lymphoedema, restricted movement of shoulder girdle, back symptoms, lymphoedema of the arm and cosmetic issues. Although long-term complications between surgical groups did not differ, there was a trend towards more grade II and III complications 22 after ALD reconstruction ( Table 1) .
Long-term effects on patient-reported outcomes after immediate reconstruction
The mean change in domain scores from baseline at 2 and 3 years after breast reconstruction (ALD and LDI groups pooled) are presented as a radar chart (Fig. 2) . Statistically significant and clinically important gains occurred in a number of psychosocial functioning scales (EORTC QLQ-C30: emotional and social functioning; FACT-B: emotional and functional well-being scales), and reductions in depression (HADS), with overall improvements in quality of life (total FACT-B) at 3 years 24 -27 . However, long-term deteriorations, also statistically significant and clinically important, occurred in physical function (QLQ-C30), body image (QLQ-BR23) and social well-being (FACT-B) at both time points. In contrast to the emotional gains noted above, the HADS anxiety scale detected persistent anxiety at 2 and 3 years 24 -27 . The mean baseline levels of PROs, along with numerical detail of the mean(s.d.) changes, can be found in Tables S1-S3 (supporting information).
Effect size and direction of effects at 2 and 3 years
Mean changes in levels of PROs from baseline to 2 and 3 years in each surgical group (Fig. 3) are shown, with the effect-size threshold of ±0⋅5 standard deviations indicating unequivocal clinical significance 27 . This univariable analysis provides important clinical insights into women's experiences in the two reconstruction groups, and the PRO effect sizes facilitate interpretation of their magnitude and direction. There were no statistically significant differences in change in PRO levels between the two types of breast reconstruction.
For each breast reconstruction type, there were clinically unequivocal changes in PROs from baseline levels at 2 years (Fig. 3a) , with the ALD group experiencing notable improvements in breast symptoms, but worsened physical function and arm symptoms. In contrast, the LDI group experienced improved levels of depression and functional well-being. At 2 years, despite women in both reconstruction groups experiencing clinically unequivocal improvements in emotional function and well-being, they also experienced heightened anxiety and reductions in body image and social well-being (all with clinically significant effect sizes). Notable reductions, apparent in social well-being at 2 years, persisted at 3 years. Social well-being includes issues such as feeling close to partner and friends, and getting support from family and friends that, arguably, may relate to body image problems. By 3 years (Fig. 3b) , women in both groups experienced notable improvements in breast symptoms, and, although there were large (effect size of about 0⋅8) improvements in emotional function and well-being, both groups were also experiencing clinically unequivocal (effect size of about 0⋅5) levels of anxiety, likely related to fear of cancer recurrence 24 -27 . Levels of anxiety were greater in the ALD group, consistent with worse prognostic factors compared with the LDI group, with continued worsening anxiety from 2 to 3 years in both groups.
Importantly, reductions in body image persisted at 3 years only in women in the LDI group, and sexual function remained decreased at 3 years compared with baseline, but neither of these effects was statistically or clinically significant (Fig. 3) . Women undergoing ALD procedures experienced a trivial increased effect on overall quality of life at 3 years through increased total FACT-B scores, Red boxes indicate that the predictor was significantly associated with worse levels of the PRO subscale (P < 0⋅010), whereas the blue box indicates a significantly improved level on the PRO subscale, with the Z score and P value as shown with a small effect size on functional well-being, despite worse physical function (small effect size) and increased arm symptoms (small effect size) at this time 24 -27 .
Multivariable analyses of baseline predictors on long-term patient-reported outcomes
Some clinical and demographic characteristics were independent predictors of PROs in multiple regression analyses, with 2-and 3-year results alongside those reported at 1 year 8 . Women receiving PMRT showed deterioration in the QLQ-C30 social functioning domain (Z score −3⋅113, P = 0⋅002) at 2 years, resolving at 3 years ( Fig. 4) . There were no significant effects of chemotherapy at 2 years, but worse EORTC QLQ-BR23 arm symptoms at 3 years (Z score 2⋅860, P = 0⋅005). Younger women reported significantly worse FACT-B physical well-being (Z score −2⋅820, P = 0⋅006). The types of LD breast reconstruction surgery did not independently predict any of the PROs at 2 years, and only one at 3 years, where an immediate ALD breast reconstruction was associated with significantly improved sexual functioning (Z score 3⋅075, P = 0⋅003) relative to LDI procedures. Trends to significance for Z scores (0⋅010 < P ≤ 0⋅050) were seen where: PMRT was associated with increased EORTC QLQ-BR23 arm symptoms (2 years); chemotherapy was associated with worse EORTC QLQ-C30 physical functioning (2 years), FACT-B breast cancer subscale (2 and 3 years) and FACT-B total score (3 years); younger women experienced poorer EORTC QLQ-C30 role functioning (2 years) and total FACT-B score (3 years) (data not shown). Somewhat paradoxically, early surgical complications were associated with reduced depression (2 years), whereas late complications were associated with improvements in FACT-B social and emotional well-being (2 years), potentially reflecting increased clinical interactions 28 . There were no significant differences between the reconstruction types in PRO changes at 2 and 3 years in a second regression model adjusted for case mix (data not shown), with the exception of an interesting finding of improved sexual functioning after ALD procedures (Z score 2⋅792, P = 0⋅007).
Discussion
The present study expands on 1-year PRO follow-up data reported previously 8 , and evaluates changes in a wide range of domains at 2 and 3 years, in terms of the effect sizes, for each type of breast reconstruction. The EORTC and FACT questionnaires proved complementary, rather than substitutable 29 . These results are novel, with no previous publications or the NMBR audit specifically describing effect sizes for relevant PRO domains over this time interval 3, 8, 19, 21 . The analyses were sufficiently powered to demonstrate that, regardless of whether immediate breast reconstruction was autologous or implant-assisted, significant long-term gains were found in psychosocial functioning and reductions in depression relative to preoperative (baseline) domain scores. Despite this, however, notable deteriorations in physical function, body image and social well-being persisted at 2 and 3 years after reconstruction. However, the present study had insufficient power to detect differences between types of surgery, with some tantalizing differential patterns warranting further investigation in larger samples. Therefore, hypotheses regarding the specific PRO domains that differ over time have been generated, and provide good effect-size estimates on which to base sample-size calculations and selected PROs for a well powered study.
This study affirms the effects of known clinical characteristics on long-term PROs in women undergoing immediate reconstruction. Regression analyses showed three independent adverse predictors on PRO subscales: PMRT, chemotherapy and young age. PMRT, a likely surrogate for biologically aggressive breast cancer, was associated with significantly impaired social functioning at 2 years. Likewise, at 3 years, chemotherapy and young age may be surrogates for more aggressive disease, adversely affecting arm symptoms and physical well-being. Autologous immediate breast reconstruction (ALD) significantly improved sexual functioning at 3 years independent of other clinical and demographic variables, with no other long-term PRO effects by type of surgery. In keeping with CONSORT-PRO reporting standards 30 , establishing the effect sizes and independent significance of core PRO domains from disease-specific and surgery-specific questionnaires is crucial for the future selection of primary outcome measures in all study designs.
A Cochrane systematic review showed inadequate reporting of psychosocial functioning after immediate breast reconstructions 31, 32 . The time points and level at which psychosocial outcomes stabilize are unknown. In the NMBR audit 10 , only the proportion of women (20-40 per cent) with psychosocial issues at 18 months after immediate reconstruction was reported, with no results for effect sizes. The present study doubles the duration of follow-up of the NMBR audit to 3 years. There were distinct differences between QLQ-C30 social functioning and FACT-B social well-being 29 in this study. The former, which assesses impacts on social activities and family life, showed a significant improvement at 2 years after all reconstructions, with no effects by 3 years. By comparison, FACT-B social well-being, which evaluates impaired social support and relationships, deteriorated significantly after ALD and LDI at both 2 and 3 years. Consistent with the present study, the MBROS 19 reported a significant (P = 0⋅010) decline in social well-being (FACT-B) at 2 years after immediate breast reconstruction. However, clinical characteristics and adjuvant treatments of the MBROS cohort were omitted, making contextual comparisons difficult. The previously reported results from the present authors 8 showed adverse effects of chemotherapy (P = 0⋅001) and early complications (P = 0⋅001) on social well-being at 1 year that had dissipated by 2 and 3 years respectively.
Significantly worse sexual function (EORTC QLQ-BR23) after LDI procedures was shown at 3 years. Other studies 4, 19 have not detected differences in sexual functioning either by type of breast reconstruction or by extent of breast surgery. Although sexual functioning or validated body image items were not evaluated in the MBROS cohort 19 , this study did employ a study-specific questionnaire that showed significantly improved body image at 2 years after autologous procedures compared with implant-based reconstructions. Restoration of a women's body image after mastectomy by immediate reconstruction was less than expected in the MBROS cohort 19 , another large cohort study (2000 patients) on sexuality 4 , and the present data. Surprisingly, mastectomy with breast reconstruction impacted negatively on a somewhat greater proportion (45 per cent) of women's sex lives compared with mastectomy alone (41 per cent) 4 . Although the EORTC QLQ-BR23 body image subscale showed dramatic intragroup reductions at 2 years in the present study, only sexual function (EORTC QLQ-BR23) remained a significant independent factor affecting quality of life over time compared with body image at 3 years. The significant improvements (P < 0⋅001) in general mental health and the role emotional subscale (Short Form 36; QualityMetric, Lincoln, Rhode Island, USA) at 2 years in the MBROS cohort 19 is similar to the large increases in emotional functioning and well-being observed in the present study at 2 and 3 years. However, clinically significant heightened anxiety from baseline to 2 and 3 years, with moderate effect sizes, was observed, more so after ALD procedures, potentially reflecting concerns about cancer recurrence.
Consistent with the findings of Rowland and colleagues 4 and King et al. 33 , the 1-year results show that younger women fare worse than older women across a spectrum of PRO domains. In the present cohort these were social functioning (P = 0⋅02), body image (P = 0⋅02) and anxiety (P = 0⋅01) 8 . The present analyses demonstrate the value of longer-term follow-up by showing that these problems had resolved by 2 and 3 years. However, physical well-being (FACT-B) had become significantly impaired at 3 years (P = 0⋅006). The observation that significantly worse arm symptoms (EORTC QLQ-BR23) were associated with PMRT at 2 years and chemotherapy at 3 years is likely a reflection of more aggressive disease meriting extensive treatments, rather than direct causation by either of these factors. The somewhat paradoxical observation at 2 years of associations of early surgical complications with reduced depression, and late complications with improvements in FACT-B social and emotional well-being, may be explained by potentially increased clinical interactions, enhancing patient-doctor communications and hence PROs 28 .
Specific strengths of this study are the preoperative baseline assessment of PROs and good coverage of clinical and demographic variables 18 . Uniquely, the study has integrated surgical complications and long-term effects of adjuvant treatments, particularly PMRT. Despite a prospective design, there remain methodological limitations of missing data. Cohort studies would benefit from similar operational funding and research infrastructure within clinical trials. The majority of cohort studies in breast reconstruction report 1-year data only 3 , whereas this study informs longer-term outcomes, and adds value by extending knowledge of the evolution and resolution of PROs. Some biases may remain unadjusted for through unmeasured characteristics, but all known potential predictors were assessed. The present sample size was underpowered for intergroup comparisons by different types of breast reconstruction. Despite its limited sample size, this study provides preliminary indications of the PRO domains that may differ according to reconstruction group, and preliminary estimates that can be used to determine sample sizes for future studies testing the hypotheses generated by the present results. Furthermore, the suite of PROs used here may not be responsive to all breast reconstruction surgery-specific effects on PROs.
As this study was commenced before phase 4 validation of the BREAST-Q 9 , it remains for future studies to evaluate the psychosocial and sexual well-being domains of the BREAST-Q on these specific reconstructions. Currently, there are no other known studies evaluating the long-term effect sizes of the BREAST-Q domains on which to base any meaningful comparisons with the findings described. The recently developed and phase 3-validated EORTC breast reconstruction (BRR) questionnaire 14 has the advantage of being used alongside the EORTC QLQ-C30 and QLQ-BR23 in patients with breast cancer, and could provide future confirmation of these findings. This study underlines the importance of identifying core PRO subscales/domains, such as those from the EORTC QLQ-C30, FACT-B and HADS, to be used alongside the future EORTC BRR surgery questionnaire 14 . Definitive studies investigating the differential effects of types of breast reconstruction can use the present findings to frame a priori hypotheses regarding the size and direction of expected effects, and determine sample sizes required to detect them with confidence 30 .
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